Product Information
FLUPHENAZINE DEC 125 MG/5 ML is a generic product labeled by Eugia US LLC, priced at $10.8440 per ML under NDC 55150026705. Its NADAC has been published 430 times since Jul 11, 2018.
FDA first approved this application on Oct 17, 2017. Its Orange Book therapeutic-equivalence code is AO.
Strength
125 mg/5mL
Manufacturer
Eugia US LLCNDC
55150026705
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FLUPHENAZINE DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA207739FDA Approved
10/17/2017
TE Code
AO
On Market Since
10/17/2017
Pharmacological Classes
Price Statistics
The NADAC for FLUPHENAZINE DEC 125 MG/5 ML has been published 430 times since Jul 11, 2018, and over the history we have for it it has declined 36.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.8440 per ML |
|---|---|
| All-time high | $19.1456 (Sep 12, 2018) |
| All-time low | $9.4872 (May 20, 2026) |
| 52-week high | $12.4542 |
| 52-week low | $9.4872 |
| Median price | $14.6889 |
| Average price | $14.3530 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 430 |
| Tracking since | Jul 11, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FLUPHENAZINE DECANOATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FLUPHENAZINE DECANOATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUPHENAZINE DEC 125 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for FLUPHENAZINE DEC 125 MG/5 ML, manufactured by Eugia US LLC, is $10.8440 per ML (NDC 55150026705), effective Sep 30, 2026.
How has the price of FLUPHENAZINE DEC 125 MG/5 ML changed over time?
Over the history we have for it, the NADAC for FLUPHENAZINE DEC 125 MG/5 ML has declined 36.0%. It has been tracked across 430 weekly CMS publications since Jul 11, 2018.
What are the highest and lowest recorded NADAC prices for FLUPHENAZINE DEC 125 MG/5 ML?
Since Jul 11, 2018, the NADAC for FLUPHENAZINE DEC 125 MG/5 ML has ranged from a low of $9.4872 (May 20, 2026) to a high of $19.1456 (Sep 12, 2018), with a median of $14.6889 per ML.
Are there cheaper alternatives to FLUPHENAZINE DEC 125 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of FLUPHENAZINE DEC 125 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUPHENAZINE DEC 125 MG/5 ML?
FLUPHENAZINE DEC 125 MG/5 ML (NDC 55150026705) is labeled by Eugia US LLC, and CMS classifies it as a generic product.